Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
OpenAI’s Growing Healthcare Footprint
In the first four months of 2026, OpenAI launched a suite of healthcare products, including ChatGPT Health, OpenAI for Healthcare, ChatGPT for Clinicians, and the GPT‑Rosalind biology model, and announced a $60 million acquisition of health‑data startup Torch. The moves place OpenAI alongside Microsoft and Amazon in the rapidly expanding AI‑in‑healthcare market. Research cited by Becker’s shows over 40 million Americans already use ChatGPT for health queries, underscoring the platform’s reach. OpenAI also published a policy blueprint urging broader patient data access and updated AI regulations.
Clover Health's Medicare Advantage Membership Increases by 51%
Clover Health reported a 51% year‑over‑year increase in Medicare Advantage membership, reaching 155,773 members in Q1 2026. Retention remained strong, exceeding 95% during the annual enrollment period. Financially, the company posted $160 million gross profit, a 47% rise, and $40 million adjusted...
Harbour BioMed Gains FDA Clearance for First-in-Human Study of B7H4xCD3 Bispecific Antibody HBM7004
Harbour BioMed announced FDA IND clearance to launch a Phase I first‑in‑human study of its bispecific antibody HBM7004, which targets B7H4 and CD3 in advanced solid tumors. The trial will assess safety, tolerability, pharmacokinetics and early anti‑tumor activity across multiple cancer...
FDA Rolls Out 1-Day Assessment Pilot in Bid to Refocus Inspection Resources
The FDA announced a pilot program that conducts one‑day inspectional assessments to better allocate its inspection resources. The initiative aims to streamline oversight by focusing on higher‑risk facilities while providing clearer expectations for manufacturers. Cooley’s regulatory partner Sonia Nath said...
Why Cook County Health’s Medicaid Coverage Loss Strategy Is Drawing Attention
Cook County Health, one of the nation’s largest public health systems, launched the Get Medicaid Facts microsite and a free communications toolkit to help Illinois residents navigate upcoming Medicaid eligibility changes. The initiative targets roughly 400,000 potential coverage losses projected...
Not Just Arthritis: A Joint Effort to Change Arthritis Care in Canada
Arthritis Society Canada released its 2026 State of Arthritis Report Card, revealing that one in five Canadians—more than those with diabetes, heart disease, cancer, stroke and dementia combined—live with arthritis, and half are under 65, including 25,000 children. Despite a...
Akron Children’s Chosen for Former Ohio College Campus Site
Akron Children’s Hospital won the bid for the former Notre Dame College campus, a nearly 50‑acre property in South Euclid, Ohio. The health system plans to convert the site into a hub for pediatric specialty services, extending its footprint in...
This Engineer Spent 100 Days Underwater—And It Added 10 Years to His Life, He Claims
Biomedical engineer Joseph Dituri spent 100 days in a 22‑foot‑deep underwater chamber at 1.6 ATA, claiming dramatic health improvements. He reported weight loss, lower cholesterol, a seven‑fold testosterone boost, and doubled REM sleep. While Dituri sees the results as proof that...
AHA Chair Authors Column in USA Today Insert on Advancing Patient Safety
American Hospital Association (AHA) Chair Marc Boom, M.D., published a column in the May 8 edition of USA Today’s special insert on patient safety. The piece underscores how hospitals and health systems are continuously raising safety standards by leveraging innovation across...
Daiichi Sankyo Posts 'Extraordinary Loss' Of Nearly $1B
Daiichi Sankyo announced it is scrapping its planned antibody‑drug‑conjugate (ADC) manufacturing line, a move that triggered an extraordinary loss of 149.4 billion Japanese yen (approximately $950 million). The loss reflects a write‑down of capital expenditures and R&D investments tied to the abandoned...
Has the Population's Liver Tolerance Changed Since 2020?
A recent analysis of NHS Hospital Episode Statistics reveals that toxic liver disease (ICD‑10 code K71) has surged 189% compared with the 2016‑2019 baseline, affecting every adult age group. The increase is concentrated in the unspecified (K71.9) and hepatitis‑NEC (K71.6)...
Trauma-Informed Spiritual Care Vital for Dying Veterans
Hospices are urged to adopt trauma‑informed, military‑culture‑aware spiritual care models to better serve dying veterans, according to Darrell Robinson of SpirituWell and Emory Healthcare. Recent studies reveal veterans often experience moral injury, survivor’s guilt, and unaddressed combat‑related trauma that resurfacing...
Rethinking Diabetes: Why Our Treatment Fails Millions
Ever wonder how we got in such a screwed up situation in the misguided way that we treat Type 2 diabetes and the resulting suffering of millions? Well, garytaubes spells it out for us all in chilling detail in his brilliant...
AI-Driven Bioterrorism Threat Demands Strong CDC‑WHO Collaboration
Why we still need a functional CDC and cooperation with the WHO. The chances of an AI-enhanced bioterrorism event in the world is not zero.
Bruno Vision Care Wins 2026 MedTech Breakthrough Award
Bruno Vision Care’s Deseyne® daily‑disposable contact lens, the first FDA‑cleared Extended Depth of Focus (EDOF) lens for presbyopia, won the 2026 MedTech Breakthrough Award for Best New Technology Solution – Ophthalmology. The lens uses a patented hyper‑refractive central zone and...
Narcan Distribution vs Costly Interventions:
Does anyone have insights on relative impact on drug overdose deaths of the wide distribution of Narcan vs the other (far more expensive) interventions we have put in place?
How Expert Guidelines Have Influenced TAVR Vs. SAVR Decisions
New analysis presented at the AATS 2026 meeting shows that the 2020 ACC/AHA valvular disease guidelines halted the decline of surgical aortic valve replacement (SAVR) and stabilized its volume after years of erosion by transcatheter aortic valve replacement (TAVR). The...
BioWorld and Nasdaq Stock Indices
BioWorld’s May briefs highlight three distinct biotech developments. Researchers at the La Jolla Institute for Immunology have isolated human antibodies that neutralize measles by blocking viral entry, a timely advance as global measles vaccination rates slip. Meanwhile, eight confirmed hantavirus...
New Kind of Liver Cell May Protect Against Common Liver Disease
Researchers at the University of Michigan identified a previously unknown hepatocyte subpopulation that emerges only in metabolic dysfunction‑associated steatohepatitis (MASH) livers. The new cells exhibit high expression of the immune‑related gene THEMIS, which regulates cellular senescence. Mouse experiments showed that...
Smart Hospitals Market to Reach $363.9 Billion by 2032, DataM Intelligence Reports, Driven by AI Clinical Workflows and Connected Care
DataM Intelligence projects the global smart‑hospital market to expand from $58.2 billion in 2024 to $363.9 billion by 2032, a 26.2% compound annual growth rate. The surge is driven by AI‑enabled clinical workflows, connected patient rooms, and remote monitoring that move health...
Being Overweight May Lead to Faster Cognitive Decline
A 24‑year longitudinal study of more than 8,200 U.S. adults over 50 found that higher body‑mass index (BMI) accelerates cognitive decline, affecting memory, executive function and emotional regulation. Each unit increase in BMI was associated with a faster deterioration of...
Some Gene Therapies No Longer Require Clinical Trials, Thanks to New FDA Rule. Is This Safe, and Who Will It...
The FDA has introduced a "plausible mechanism pathway" that lets developers market experimental gene‑editing therapies for rare, monogenic disorders without completing traditional large‑scale clinical trials. The rule relies on prior safety data for the delivery platform and permits customization of...
AI Talent Shuns Pharma, Feeling Reduced to Code Writers
Astute @endpts article on why rising AI talent not drawn to pharma; $ part, but key reason=“Pharma might just see us as people who write code or run models for them, and not really value for research." Mirror image of...
Can Existing Flu Shots Help Protect Against Bird Flu?
Researchers from National Taiwan University and the University of South Florida analyzed 35 ferret studies spanning two decades and found that seasonal influenza vaccines containing the neuraminidase N1 protein reduced H5N1‑related mortality by roughly 73%. By contrast, vaccines without N1...
The “Goldilocks” Choice: Why Older Adults Are Turning to Cannabis
A new University of Utah and Colorado study finds adults over 60 are the fastest‑growing cannabis consumers in the U.S., driven primarily by a desire for better quality of life rather than a psychoactive high. Participants cite chronic pain, insomnia...
Wisconsin Unveils Statewide Mental‑Health Action Plan Emphasizing Telehealth and 988 Lifeline
Wisconsin Governor Tony Evers’ Interagency Council on Mental Health released a statewide action plan that calls for expanded telehealth, continued funding for the 988 crisis line, and new policies for underserved populations. The plan draws on input from more than...
Karolinska Study Finds Daily Peanut Exposure Safely Treats 82% of Toddler Allergies
Researchers at Karolinska Institutet reported that 82% of toddlers who received daily oral peanut immunotherapy could safely eat three and a half peanuts after three years, compared with just 12% in a control group. The three‑year study of 75 children...
Safety Debate Heats Up Over Stem Cell Longevity Treatments
Leading researchers and clinic founders are confronting the safety of stem‑cell therapies marketed for longevity, with experts warning that not all products are genuine stem cells and that regulatory oversight remains limited. The debate underscores a booming market driven by...
FDA Sets 2027 PDUFA Date for Taletrectinib in ROS1‑Positive Lung Cancer
The FDA has accepted Nuvation Bio’s supplemental new drug application for taletrectinib in ROS1‑positive non‑small cell lung cancer and scheduled a PDUFA decision for Jan. 4, 2027. The filing adds 10 months of phase‑2 data showing high response rates and durable disease...
Zahnarztpraxis Wallis Rolls Out Enhanced Digital Platform for Swiss Dental Patients
Zahnarztpraxis Wallis has upgraded its online dental directory with streamlined search, comparison and review features, aiming to cut geographic barriers for patients in the mountainous Valais canton. The free service now lets users filter by location, services and verified patient...
ShiftMed Teams with Skilltrade to Launch AI‑Powered Allied Health Training Platform
ShiftMed announced a strategic partnership with Skilltrade to integrate AI‑driven allied‑health training into its workforce optimization platform, aiming to close credential gaps and reduce reliance on costly contract labor. The collaboration leverages ShiftMed’s 2025 record of 631,000 supported shifts and...
5 Things to Know About the Converging Medicaid Funding Crisis
The One Big Beautiful Bill Act (OBBBA) will slash federal Medicaid spending by $1 trillion over the next decade, forcing state budgets to shrink by $664 billion and capping managed‑care rates at 100% of Medicare in expansion states and 110% elsewhere. States are expected to lower...
Rapamycin's 50-Year Odyssey: From Easter Island to Medicine
The rapamycin sTORy: 50-year journey from Easter Island to the frontiers of biology and medicine https://t.co/Jn67QrGVi6 https://t.co/dwGPgUVB83
Legionella Outbreak at Kaiser Santa Clara Hospital Sickens 18
Eighteen patients at Kaiser Santa Clara Medical Center have fallen ill after a Legionella outbreak was traced to the hospital's water system. Officials issued a health alert, treated the water supply and said the facility remains operational, while county health...
Close a Critical Gap in Hospital Security with Athena Security’s Ambulance Bay Weapons Detection System
Athena Security unveiled an AI‑powered Ambulance Bay Weapons Detection System that automatically scans patients on stretchers or wheelchairs as they pass through a dedicated scanner. The solution replaces manual hand‑wanding, reducing screening time by 30‑60 seconds per patient while delivering...
AHA Pushes Back on Families USA Report
The American Hospital Association (AHA) pushed back on a May 7 report from Families USA, calling it "long on rhetoric, short on reality." The AHA argued that hospitals are price takers, constrained by Medicare rates and insurer negotiations, and that the report...
Fewer Visits Demand Trust, Answers, and Action
Less traffic = higher stakes Every visit now has to: ✔ Build trust ✔ Answer questions ✔ Enable action Ahava Leibtag breaks it down 👉 https://t.co/GA9oYQP470 @ahamediagroup #healthcarewebsites #hcmktg
Microsoft Warns of Sophisticated Phishing Campaign Heavily Targeting Health Care Organizations
Microsoft Threat Intelligence has identified a large‑scale, multistage phishing campaign that disproportionately targeted the U.S. health‑care sector. The operation sent “code of conduct” themed emails to more than 35,000 users across 13,000 organizations, using adversary‑in‑the‑middle techniques to hijack authentication tokens...
WHOOP Expands Health Platform with On-Demand Clinician Access and New AI Features
WHOOP unveiled a suite of health‑focused upgrades, adding on‑demand video consultations with licensed clinicians and EHR syncing through HealthEx, slated for a U.S. launch this summer. The platform also introduced two AI tools—My Memory, which lets members edit personal context,...
I’m an ICU Doctor Who Treated a Critically Ill Hantavirus Patient. Here’s What Everyone Should Know.
A 14‑year‑old patient in Ohio was diagnosed with hantavirus pulmonary syndrome after a week of severe respiratory failure, requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). The disease carries a 35‑47% mortality rate and lacks a specific antiviral, making supportive...
Guiding Patients Through Cancer Care With Compassion, Historical Perspective: Deborah Doroshow, MD, PhD
In an AJMC interview, Dr. Deborah Doroshow, an assistant professor at Mount Sinai’s Tisch Cancer Institute, describes her role as a guide for cancer patients and families, emphasizing plain‑language communication and staged information delivery. She splits her clinical work between...
I Barely Survived Hantavirus. This Is What It's Really Like.
Carina Hsieh’s feature recounts 18‑year‑old Evie H.’s battle with hantavirus pulmonary syndrome, a rare rodent‑borne disease with a 35‑47% fatality rate. After a headache escalated to respiratory failure, she was rushed to Cincinnati Children’s Hospital, where doctors performed CPR, placed...
Japan’s FY26 Price Revision Expands G1 Repricing and Drives Price Reduction
Japan’s FY26 National Health Insurance drug price revision took effect in April 2026, lowering average prices by 4.02% across about 15,800 products. The revision expands the G1 repricing rule to all off‑patent medicines and biologics with biosimilar competition, driving price...
Health Tech World Brings NHS Procurement Insider to Exclusive AI Event
Health Tech World’s in‑person event "Unlocking the Healthcare AI Opportunity" adds Hugo Dragonetti, procurement and systems manager at NHS London Procurement Partnership, as its fifth panelist. The conference, co‑hosted with Teesside University London, will dissect the current state of AI...
Health Firms Odyssey, Mobia Fall After $454 Million IPO Haul
Odyssey Therapeutics and Mobia Health debuted on the Nasdaq, together raising about $454 million—$304 million for Odyssey and $150 million for Mobia after an upsized IPO and a private placement. Despite the strong capital infusion, Odyssey’s shares fell 8.8 % in early trading, and...
Tandem to File Tubeless Insulin Pump with FDA This Quarter
Tandem Diabetes Care will file a 510(k) this quarter for a tubeless version of its Mobi insulin pump, aiming for FDA clearance in the second half of 2026. The company reported Q1 revenue of $247.2 million, a 5 % year‑over‑year increase, while...
ZYME ADC
Catching up with $ZYME pan-RAS inhibitor payload ADCs from #AACR26. Seems the setting for each one is tumours that are RAS-mutated as well as expressing the target antigen (PTK7, Ly6E or Claudin18.2). https://t.co/hljX5soZQi
FDA Greenlights Fruit-Flavored Vapes, Sparking Controversy
The FDA finally authorized fruit-flavored vapes. It's quite a story. @imaracingmom explains in @Filtermag_org #smoking #vaping https://t.co/11alD0xXCP
Contact Tracing Could Be Key in Halting the Spread of Hantavirus. Here's How It Works
An international public‑health team is tracing more than two dozen passengers who left the MV Honius cruise ship after a hantavirus case was identified. Because the virus requires close, prolonged exposure and transmits only briefly, officials assess the risk of...
Withings Report Reveals Why Menopause Is a Critical Cardiovascular Window
Withings' 2026 Menopause Transition report, based on data from 2.5 million women in 11 countries, shows menopause is a pivotal cardiovascular window. Atrial fibrillation prevalence jumps fourfold globally and 3.8 times in the U.S. between early reproductive years and late post‑menopause. Heart‑rate...